{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:50:01Z","timestamp":1790909401716,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008386","name":"Marmara \u00dcniversitesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008386","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.clnesp.2025.05.005","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T17:49:33Z","timestamp":1746726573000},"page":"267-273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The relationship between bacterial changes and dietary intervention in non-alcoholic fatty liver disease"],"prefix":"10.1016","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-4817-5999","authenticated-orcid":false,"given":"Esma","family":"O\u011fuz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4518-5283","authenticated-orcid":false,"given":"Yusuf","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0334-7598","authenticated-orcid":false,"given":"Fatma Esra","family":"G\u00fcne\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnesp.2025.05.005_bib1","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.metabol.2016.01.012","article-title":"Epidemiology and natural history of non-alcoholic fatty liver disease","volume":"65","author":"Fazel","year":"2016","journal-title":"Metabolism"},{"issue":"6","key":"10.1016\/j.clnesp.2025.05.005_bib2","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.clnesp.2025.05.005_bib3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev-pathol-121808-102132","article-title":"Nonalcoholic fatty liver disease: pathology and pathogenesis","volume":"5","author":"Tiniakos","year":"2010","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.clnesp.2025.05.005_bib4","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.jhep.2015.07.036","article-title":"Treating liver fat and serum triglyceride levels in NAFLD, effects of PNPLA3 and TM6SF2 genotypes: results from the WELCOME trial","volume":"63","author":"Scorletti","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.clnesp.2025.05.005_bib5","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1017\/S0007114514002591","article-title":"Non-alcoholic fatty liver disease: need for a balanced nutritional source","volume":"112","author":"Veena","year":"2014","journal-title":"Br J Nutr"},{"key":"10.1016\/j.clnesp.2025.05.005_bib6","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jaut.2013.07.001","article-title":"Role of the intestinal microbiome in liver disease","volume":"46","author":"Henao-Mejia","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.clnesp.2025.05.005_bib7","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1210\/jc.2012-3093","article-title":"Clinical review: nonalcoholic fatty liver disease: a novel cardiometabolic risk factor for type 2 diabetes and its complications","volume":"98","author":"Targher","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.clnesp.2025.05.005_bib8","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.jaci.2012.03.010","article-title":"The interpersonal and intrapersonal diversity of human-associated microbiota in key body sites","volume":"129","author":"Ursell","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.clnesp.2025.05.005_bib9","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/hep.26093","article-title":"Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH","volume":"57","author":"Zhu L., Baker S.S., Gill C., Liu W., Alkhouri R., Baker R.D.","year":"2013","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.clnesp.2025.05.005_bib10","doi-asserted-by":"crossref","first-page":"62885","DOI":"10.1371\/journal.pone.0062885","article-title":"Molecular characterization of the fecal microbiota in patients with nonalcoholic steatohepatitis: a longitudinal study","volume":"8","author":"Wong","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.clnesp.2025.05.005_bib11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/MCG.0b013e31824cf51e","article-title":"The role of nutrients in the development, progression, and treatment of nonalcoholic fatty liver disease","volume":"46","author":"Mouzaki","year":"2012","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.clnesp.2025.05.005_bib12","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1194\/jlr.R036012","article-title":"The role of short-chain fatty acids in the interplay -between diet, gut microbiota, and host energy metabolism","volume":"54","author":"Den Besten","year":"2013","journal-title":"J Lipid Res"},{"key":"10.1016\/j.clnesp.2025.05.005_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063388","article-title":"Butyrate-producing probiotics reduce nonalcoholic fatty liver disease progression in rats: new insight into the probiotics for the gut-liver axis","volume":"8","author":"Endo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.clnesp.2025.05.005_bib14","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1210\/jc.2015-4251","article-title":"Mechanisms linking the gut microbiome and glucose metabolism","volume":"101","author":"Utzschneider","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clnesp.2025.05.005_bib15","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1128\/AEM.66.4.1654-1661.2000","article-title":"Phylogenetic relationships of butyrate-producing bacteria from the human gut","volume":"66","author":"Barcenilla","year":"2000","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.clnesp.2025.05.005_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1123547","article-title":"Faecalibacterium prausnitzii prevents hepatic damage in a mouse model of NASH induced by a high-fructose high-fat diet","volume":"14","author":"Shin","year":"2023","journal-title":"Front Microbiol"},{"issue":"14","key":"10.1016\/j.clnesp.2025.05.005_bib17","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.3390\/nu14142945","article-title":"Specific strains of Faecalibacterium prausnitzii ameliorate nonalcoholic fatty liver disease in mice in association with gut microbiota regulation","volume":"14","author":"Hu","year":"2022","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.clnesp.2025.05.005_bib18","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3390\/biology13040243","article-title":"Intestinal barrier dysfunction and gut microbiota in non-alcoholic fatty liver disease: assessment, mechanisms, and therapeutic considerations","volume":"13","author":"Long","year":"2024","journal-title":"Biology"},{"issue":"11\u201312","key":"10.1016\/j.clnesp.2025.05.005_bib19","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.nut.2008.05.017","article-title":"High-fat diet: a trigger of non-alcoholic steatohepatitis? Preliminary findings in obese subjects","volume":"24","author":"Vilar","year":"2008","journal-title":"Nutrition"},{"issue":"3","key":"10.1016\/j.clnesp.2025.05.005_bib20","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10620-020-06112-w","article-title":"Diet and the human gut microbiome: an international review","volume":"65","author":"Wilson","year":"2020","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clnesp.2025.05.005_bib21","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1053\/j.gastro.2012.01.034","article-title":"A high-fat diet is associated with endotoxemia that originates from the gut","volume":"142","author":"Pendyala","year":"2012","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.clnesp.2025.05.005_bib22","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1499-3872(17)60019-5","article-title":"Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease","volume":"16","author":"Shen","year":"2017","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.clnesp.2025.05.005_bib23","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.clnesp.2025.05.005_bib24","series-title":"Turkey Nutrition Guideline (TUBER)","year":"2022"},{"issue":"1","key":"10.1016\/j.clnesp.2025.05.005_bib25","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases (AASLD)","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.clnesp.2025.05.005_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2021.1888673","article-title":"Links between gut microbiome composition and fatty liver disease in a large population sample","volume":"13","author":"Ruuskanen","year":"2021","journal-title":"Gut Microbes"},{"issue":"5","key":"10.1016\/j.clnesp.2025.05.005_bib27","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41575-020-0269-9","article-title":"Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders","volume":"17","author":"Aron-Wisnewsky","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.clnesp.2025.05.005_bib28","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1210\/jc.2015-3351","article-title":"Two healthy diets modulate gut microbial community improving insulin sensitivity in a human obese population","volume":"101","author":"Haro","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.clnesp.2025.05.005_bib29","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1038\/ismej.2017.24","article-title":"Faecalibacterium prausnitzii treatment improves hepatic health and reduces adipose tissue inflammation in high-fat fed mice","volume":"11","author":"Munukka","year":"2017","journal-title":"ISME J"},{"issue":"21","key":"10.1016\/j.clnesp.2025.05.005_bib30","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/femsle\/fnv176","article-title":"Enhanced butyrate formation by cross-feeding between Faecalibacterium prausnitzii and Bifidobacterium adolescentis","volume":"362","author":"Rios-Covian","year":"2015","journal-title":"FEMS Microbiol Lett"},{"issue":"5","key":"10.1016\/j.clnesp.2025.05.005_bib31","doi-asserted-by":"crossref","first-page":"388","DOI":"10.2174\/0929866524666170220113312","article-title":"Dietary fiber gap and host gut microbiota","volume":"24","author":"Han","year":"2017","journal-title":"Protein Pept Lett"},{"key":"10.1016\/j.clnesp.2025.05.005_bib32","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/ijo.2008.155","article-title":"Human colonic microbiota associated with diet, obesity and weight loss","volume":"32","author":"Duncan","year":"2008","journal-title":"Int J Obes"},{"issue":"4","key":"10.1016\/j.clnesp.2025.05.005_bib33","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1128\/AEM.02340-06","article-title":"Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces","volume":"73","author":"Duncan","year":"2007","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.clnesp.2025.05.005_bib34","series-title":"Prebiotics and probiotics-potential benefits in nutrition and health","article-title":"Functional attributes and health benefits of novel prebiotic oligosaccharides derived from xylan, arabinan, and mannan","author":"Saville","year":"2019"},{"issue":"10","key":"10.1016\/j.clnesp.2025.05.005_bib35","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1089\/ars.2012.4701","article-title":"How can Faecalibacterium prausnitzii employ riboflavin for extracellular electron transfer?","volume":"17","author":"Khan","year":"2012","journal-title":"Antioxidants Redox Signal"},{"issue":"4","key":"10.1016\/j.clnesp.2025.05.005_bib36","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00886-20","article-title":"Vitamin biosynthesis by human gut butyrate-producing bacteria and cross-feeding in synthetic microbial communities","volume":"11","author":"Soto-Martin","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.clnesp.2025.05.005_bib37","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/ejcn.2016.119","article-title":"The prebiotic concept and human health: a changing landscape with riboflavin as a novel prebiotic candidate","volume":"70","author":"Steinert","year":"2016","journal-title":"Eur J Clin Nutr"},{"issue":"3","key":"10.1016\/j.clnesp.2025.05.005_bib38","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3390\/nu11030613","article-title":"Dietary nutrients involved in one-carbon metabolism and colonic mucosa-associated gut microbiome in individuals with an endoscopically normal colon","volume":"11","author":"Gurwara","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.clnesp.2025.05.005_bib39","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.3389\/fmicb.2019.01316","article-title":"Micronutrient requirements and sharing capabilities of the human gut microbiome","volume":"10","author":"Rodionov","year":"2019","journal-title":"Front Microbiol"},{"issue":"2","key":"10.1016\/j.clnesp.2025.05.005_bib40","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1016\/j.jhep.2023.08.013","article-title":"Sex differences in prevalence and prognosis of steatotic liver disease phenotypes: biological sex matters","volume":"80","author":"Ji","year":"2024","journal-title":"J Hepatol"},{"issue":"Suppl 1","key":"10.1016\/j.clnesp.2025.05.005_bib41","article-title":"Gender differences in nonalcoholic fatty liver disease","volume":"12","author":"Nagral","year":"2022","journal-title":"Eurasians J Hepato-Gastroenterol"},{"issue":"8","key":"10.1016\/j.clnesp.2025.05.005_bib42","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1111\/liv.14943","article-title":"Clinical impact of sexual dimorphism in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)","volume":"41","author":"Burra","year":"2021","journal-title":"Liver Int"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240545772500302X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240545772500302X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T17:28:13Z","timestamp":1762622893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240545772500302X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":42,"alternative-id":["S240545772500302X"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2025.05.005","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The relationship between bacterial changes and dietary intervention in non-alcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2025.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}